Liqiang Wang

State Key Laboratory Of Respiratory Disease
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test.

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test.

Journal: Human vaccines & immunotherapeutics

Published: February 17, 2026

Novel circulating microRNA signature for early detection and prognostication of checkpoint inhibitor-related pneumonitis.

Novel circulating microRNA signature for early detection and prognostication of checkpoint inhibitor-related pneumonitis.

Journal: Journal for immunotherapy of cancer

Published: August 26, 2025

The survival analysis of stage III and IV inoperable lung large cell neuroendocrine carcinoma and the role of LIPI in immunological stratification.

The survival analysis of stage III and IV inoperable lung large cell neuroendocrine carcinoma and the role of LIPI in immunological stratification.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 04, 2024

A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma.

A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma.

Journal: BMC cancer

Published: May 21, 2024

A Nomogram for Predicting Cancer-Specific Survival in Young Patients With Advanced Lung Cancer Based on Competing Risk Model.

A Nomogram for Predicting Cancer-Specific Survival in Young Patients With Advanced Lung Cancer Based on Competing Risk Model.

Journal: The clinical respiratory journal

Published: September 03, 2023

Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients.

Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients.

Journal: Human vaccines & immunotherapeutics

Published: August 01, 2023

Real-world data on severe lung cancer: a multicenter retrospective study.

Real-world data on severe lung cancer: a multicenter retrospective study.

Journal: Translational lung cancer research

Published: November 18, 2022

Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer.

Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer.

Journal: Respiratory research

Published: March 01, 2022

Dual Immunotherapy in Advanced Non-small Cell Lung Cancer:  the Progress and Clinical Application

Dual Immunotherapy in Advanced Non-small Cell Lung Cancer:  the Progress and Clinical Application

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: February 28, 2022

Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.

Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.

Journal: Frontiers in immunology

Published: February 20, 2022

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI.

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI.

Journal: Frontiers in oncology

Published: April 25, 2021

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.

Journal: Frontiers in oncology

Published: February 26, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026